pioneer 6 semaglutide Cardiovascular, Metabolic, and Safety Outcomes with by Baseline Age: Post Hoc Analysis of SUSTAIN and 6 | Diabetes Therapy Effect of semaglutide versus placebo
Description
Insulin resistance is a core problem with PCOS that is the cause of more than just weight gain
Discuss GLP1 dosing and titration with a clinician if symptoms track with Ozempic use or other weight loss medications
Most FDA-approved injections were pre-filled in 0.25 mg or 0.5 mg increments
After eligibility determination, 358 articles were excluded, leaving 26 articles to be used for analysis
Individual results may vary and depend on factors such as adherence, lifestyle changes, and biological response to treatment
